Buy Cover Before Genetic Testing? Usually Not

If you are about to have a genetic test in the UK and you are wondering whether to get life insurance in place before you do, the honest answer is that you almost certainly do not need to rush. In this country the result of a predictive genetic test cannot be asked for on a normal life insurance application. Taking the test does not spoil your chances of cover, and it does not have to be raced against a policy start date.

That instinct to buy first is real, and it is not stupid. It is simply imported. Most of the advice online telling you to secure a policy before you are tested is American, written under American rules, where life insurers can and do use genetic results. The UK runs on a different arrangement: a voluntary agreement between the government and the insurance industry called the Code on Genetic Testing and Insurance, which keeps predictive results out of underwriting for the overwhelming majority of applications.

So the question worth asking is not really whether to test or insure first. It is what this test actually leads to. Because the one thing that can reach an insurer is not the result itself, but the medical care that follows from it.

The short answer, in the UK

Under the Code, insurers that have signed up to it — which in practice means the firms selling almost all UK life cover — will not ask you to take a predictive genetic test, and will not ask for the result of one you have already had. A predictive result is one taken while you have no symptoms, to estimate a future risk. It sits outside the questions on the form. You do not have to volunteer it, and if you leave it out you are not withholding anything you were obliged to give.

That is why the timing question mostly dissolves. If the result cannot be asked for, then having the test before you apply, or after, or in the same week, makes no difference to how that result is treated. There is no window to beat and no penalty to outrun. The Code has done this job since 2018, when it replaced the older moratorium on genetics and insurance, and unlike that moratorium it has no expiry date built into it.

None of this removes the ordinary questions. You will still be asked about your own health, your height and weight, whether you smoke, and — importantly — about your family history in plain terms, such as whether a parent or sibling had a serious condition before a certain age. Those questions are fair game and must be answered with reasonable care. What is off the table is the specific thing a lot of people are frightened of: a predictive gene result being pulled into the decision.

Why the "buy cover first" advice is American

In the United States, a federal law usually shortened to GINA stops health insurers and employers using genetic information about a person. Crucially, it stops there. It does not cover life insurance, disability cover or long-term care insurance, and in a number of states a life insurer is free to ask for and act on a genetic result. In that world, "get your life policy locked in before you test" is genuinely sound advice, which is exactly why it is repeated so confidently across the internet.

Dropped into a UK search, that advice misleads. The protection you have here does not come from an anti-discrimination law at all. It comes from the Code, an agreement administered with the Association of British Insurers, under which insurers promise not to use predictive results within generous financial limits. The mechanism is different, and so is the answer. Reading American guidance and then rushing to buy before an NHS test is solving a problem you do not actually have.

It is an easy mistake to make, because the American articles are numerous, fluent and certain, and they rank well. If you have read three of them in a row telling you to hurry, the UK reality can feel too good to be true. It is not. It is simply a different regime.

Predictive versus diagnostic: the line that matters

The Code draws one line that decides almost everything, and it is worth getting straight before you do anything else. A predictive, or presymptomatic, test looks for a risk before any illness has appeared — you feel well, and the test estimates the chance of something in the future. A diagnostic test is done to explain something that is already happening: a symptom, an abnormal scan, a suspicious finding, and to name the condition causing it.

Only the predictive result is protected. A diagnostic result is part of your medical history in the ordinary way, because it describes a condition you actually have rather than a risk you might carry. If you were tested because a doctor was investigating symptoms, that test and its result are disclosable where the application asks about your health, your investigations or your diagnoses. If you were tested purely to look into the future while entirely well, that result stays off the form.

This is why two people can have "the same test" and be in completely different positions. One had it to chase a symptom; the other had it out of caution with a clean bill of health. The gene is identical. The status under the Code is not.

What a test can still lead to that an insurer may see

This is where the real nuance lives, and it is the part the American articles get closest to being right about, just for the wrong reason. The test result is protected. What the result sets in motion may not be.

A predictive result showing a raised risk often leads somewhere clinically. You might be placed under regular surveillance — scans, blood tests, colonoscopies. You might be started on medication. You might be offered risk-reducing surgery. Each of those is an ordinary medical fact. If a later application asks whether you take any regular medication, or have had any operations, or are under specialist follow-up, you answer about the care, not about the gene. A PSA blood test taken after a father's prostate cancer, for example, is not a genetic test at all, so nothing in the Code shields it: if it is in your record and you are asked, it can be seen and weighed.

So the sequence matters more than the label. The gene test is invisible to the underwriter; the pathway it opens may not be. That is not a reason to avoid surveillance or treatment — you absolutely should not — but it does explain why "the test changes nothing" is not quite true, even in the UK. It also explains why, for a family already living with something like a parent's early-onset dementia, the useful question is rarely about the gene test and almost always about what cover can still do around the medical facts that are already known.

The one exception: Huntington's above £500,000

There is a single place where the timing question comes back to life, and it is narrow. The Code allows an insurer to ask about the result of a predictive test in one specified situation: a test for Huntington's disease, and only where the total life cover being applied for is above a set figure.

Source: HM Government and the Association of British Insurers, Code on Genetic Testing and Insurance.

That figure is £500,000 of life cover. Below it, even a Huntington's result cannot be asked for. Above it, and for that one condition alone, it can. Huntington's is singled out because it is a single-gene condition with a very high and well-understood link between carrying the fault and developing the disease — precisely the situation where, if you had tested positive and knew a large policy was about to be arranged, buying first would be a genuine form of the problem insurers worry about. No other condition is currently on that list. Not BRCA, not the APOE variant reported by ancestry kits, not the inherited cardiac genes.

If you are near that half-million threshold and a Huntington's test is a live possibility for you specifically, this is the one scenario where the order can genuinely matter. It is worth taking proper advice from an FCA-authorised broker before you apply, rather than assuming either way.

When buying cover first does — and does not — help

Strip out the myth and a short, real list remains of when getting cover in place first is sensible, and most of it has nothing to do with the gene test itself.

• If you already have symptoms, a referral or a diagnosis in progress. Those are disclosable, and an insurer may postpone a decision while they are unresolved. Applying before things escalate can be reasonable — but that is about your medical situation, not about a predictive test.
• If you are genuinely near the Huntington's threshold. Covered above, and rare.
• If your family history alone already shapes the terms. Here the answer is often more reassuring than feared. A family history is usually priced far more mildly than people expect, and it is not a reason to reach for the most expensive product in the market. It is worth seeing how a family history is actually priced on a mortgage-linked policy before assuming the worst.

What almost never belongs on that list is "because I am about to have a predictive test". If the result cannot be asked for, waiting does not weaken your application. And the cost of getting this wrong is not financial, it is medical. People who have watched a family go through an uninsured death sometimes over-correct, and delay a test they clinically need in order to arrange a policy first.

If you have decided you want cover in place for ordinary reasons — a mortgage, or a family that depends on your income — and not because of a test at all, you can get life insurance quotes and have a broker price level term cover against your actual circumstances. That decision stands on its own merits, whatever you do about testing.

Scotland, Northern Ireland and the rest of the UK

The Code is a UK-wide agreement, so the core rule is the same in England, Wales, Scotland and Northern Ireland: a predictive genetic result cannot be asked for on a standard life application anywhere in the UK, within the same financial limits. What differs between the nations is not the insurance rule but the health service around the test. NHS genetics services, referral routes and waiting times are run separately in each nation, and the records you can and cannot obtain about your own background follow different systems too.

None of that changes what an insurer may ask. It only changes how and when you get tested in the first place. The wider picture — what a family history does and does not mean for your own odds — sits in our guide to family history, inherited risk and the odds.

Frequently asked questions

Should I buy life insurance before having a genetic test in the UK?

Usually there is no need. The result of a predictive genetic test cannot be asked for on a standard life application, so waiting until after the test does not disadvantage you in the way American articles suggest. The one exception is a predictive test for Huntington's disease where the total life cover applied for would exceed £500,000, in which case the order genuinely can matter.

Does the test change anything at all?

It can, but indirectly. If a result leads to surveillance, medication, a diagnosis or preventive surgery, those are ordinary medical facts that a later application may ask about. So it is the clinical care that follows a test, rather than the gene result itself, that can reach an underwriter. The result stays protected; the care around it does not.

Is delaying a test to get cover first a good idea?

Rarely, and it carries a real cost. Postponing a test postpones the screening or treatment it would have led to, and a review of the Code has specifically noted that fear of insurance consequences can deter people from tests they clinically need. Discuss the timing with your genetics team rather than with an insurer.